What do I do if I am denied or delayed in receiving biopolymer and SMNP services?

It can be activated (preferably in a staggered manner): Right of petition to the EPS (requesting priority agenda, authorisations, referral network, clinical and administrative justification). Complaint to the National Superintendence of Health for barriers to access and health risk. Action for protection if the barrier affects the right to health in a serious/urgent way (for [...]

What is the care pathway you should follow within the EPS?

The EPS must ensure coverage of the diagnosis and treatment prescribed by the treating physician, with a focus on comprehensiveness and continuity, without turning the procedure into a barrier. The care must allow for specialised assessments, examinations, necessary procedures, pain management, comprehensive treatment and continuity, in accordance with the unified rules and their administrative implementation.

What are "permitted" and "non-permitted" modelling substances?

In Colombia, this distinction is used to refer to injectable body fillers that are on the official list issued by the Ministry of Health and INVIMA. Non-permitted" are invasive and injectable substances that do not appear on this list and are used without the proper authorisation from the health authorities.